Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Review Article

Tanta Protocol for Management of COVID-19: Perspectives from a Developing Country

Author(s): Sherief Abd-Elsalam*, Eslam Saber Esmail, Mai Khalaf, Ghada N. El-Sarnagawy, Shahinaz M Shalaby, Mohamed Samir Abd El Ghafar, Mohamed Elbahnasawy, Asem Elfert, Hanan Soliman, Ferial El-kalla and Ahmed Ghoneim

Volume 21 , Issue 10 , 2021

Published on: 17 November, 2020

Page: [1775 - 1780] Pages: 6

DOI: 10.2174/1871530320999201117142305

Price: $65

Abstract

In late 2019, SARS-COV-2 disease was firstly discovered in Wuhan, China and then it infected millions of people worldwide. Later, the World Health Organization (WHO) described COVID-19 as the first pandemic invading the world in the 21st century. The WHO has declared that the emerging infection will last long enough to force adjustments not only in people's lifestyles but also in the health care system. This amendment is expected to spread through many medical practices and specialties. A lot of diagnostic and therapeutic modalities have been proposed for COVID-19 management. The best strategy for the management of patients requires a multi-disciplinary team approach with correct decisions regarding the right timing of each modality of treatment. The participating multidisciplinary team for COVID-19 management includes six infectious diseases experts in Tanta University; one critical care management expert, an emergency medicine expert and two pharmacists in Tanta University. In this review, we reported our multi-disciplinary team experience with up to date literature guidance to propose a valid protocol for the management of COVID-19 patients in a limited resources setting.

Keywords: Coronavirus infection, diagnosis, serology, PCR, treatment, chloroquine.

Graphical Abstract

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy